2007 WHA Resolution on tuberculosis control: progress and long-term planning

60th WHA
23 May 2007

Res­o­lu­tion WHA60.19

Down­load

Source

Analysis of precedential value

The World Health Assem­bly (WHA) is the deci­sion-mak­ing body of the World Health Orga­ni­za­tion. It includes del­e­ga­tions from every UN mem­ber state, which gather annu­ally to address ques­tions about WHO’s gov­er­nance, bud­get, and progress. Although WHA res­o­lu­tions are cen­tred on health, they engage var­i­ous related top­ics rang­ing from mil­i­tary aggres­sion to migrant rights.

Used as precedent

access to health products

• “Urges all mem­ber states to develop and imple­ment long-term plans for tuber­cu­lo­sis pre­ven­tion and con­trol in line with the Global Plan to Stop TB 2006–2015, in the con­text of over­all health devel­op­ment plans, in col­lab­o­ra­tion with other pro­grammes (includ­ing those on HIV/AIDS, child health and strength­en­ing of health sys­tems), and through national Stop TB part­ner­ships where appro­pri­ate, with the aim of con­trol­ling the emer­gence and trans­mis­sion of multi-drug-resis­tant tuber­cu­lo­sis, includ­ing exten­sively drug-resis­tant tuber­cu­lo­sis, by ensur­ing the high-qual­ity imple­men­ta­tion of the DOTS strat­egy and by prompt imple­men­ta­tion of infec­tion-con­trol pre­cau­tions.” (para­graph 1(1)(d))

• “Urges all mem­ber states to develop and imple­ment long-term plans for tuber­cu­lo­sis pre­ven­tion and con­trol in line with the Global Plan to Stop TB 2006–2015, in the con­text of over­all health devel­op­ment plans, in col­lab­o­ra­tion with other pro­grammes (includ­ing those on HIV/AIDS, child health and strength­en­ing of health sys­tems), and through national Stop TB part­ner­ships where appro­pri­ate, with the aim of: if affected, imme­di­ately address­ing exten­sively drug-resis­tant tuber­cu­lo­sis and HIV-related tuber­cu­lo­sis as part of the over­all Stop TB strat­egy, as the high­est health pri­or­i­ties.” (para­graph 1(1)(e))

• “Requests the direc­tor-gen­eral to strengthen urgently WHO’s sup­port to coun­tries affected by mul­tidrug-resis­tant tuber­cu­lo­sis and espe­cially exten­sively drug-resis­tant tuber­cu­lo­sis, and to coun­tries highly affected by HIV-related tuber­cu­lo­sis.” (para­graph 2(3))

• “Requests the direc­tor-gen­eral to sup­port Mem­ber States in devel­op­ing lab­o­ra­tory capac­ity to pro­vide for rapid drug-sus­cep­ti­bil­ity test­ing of iso­lates obtained from all per­sons with cul­ture-pos­i­tive tuber­cu­lo­sis, to develop con­sen­sus guide­lines for rapid drug-sus­cep­ti­bil­ity test meth­ods and appro­pri­ate mea­sures for lab­o­ra­tory strength­en­ing, and to mobi­lize fund­ing.” (para­graph 2(3))

key and vulnerable populations

• “Requests the direc­tor-gen­eral to strengthen mech­a­nisms to review and mon­i­tor esti­mates of impact of con­trol activ­i­ties on the tuber­cu­lo­sis bur­den, includ­ing inci­dence, preva­lence and mor­tal­ity with spe­cific atten­tion to vul­ner­a­ble groups highly at risk, such as poor peo­ple, migrants and eth­nic minori­ties.” (para­graph 2(3))